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Abstract
mRNA synthesis, processing, and destruction involve a complex series of molecular steps that are incompletely understood.
Because the RNA intermediates in each of these steps have finite lifetimes, extensive mechanistic and dynamical
information is encoded in total cellular RNA. Here we report the development of SnapShot-Seq, a set of computational
methods that allow the determination of in vivo rates of pre-mRNA synthesis, splicing, intron degradation, and mRNA decay
from a single RNA-Seq snapshot of total cellular RNA. SnapShot-Seq can detect in vivo changes in the rates of specific steps
of splicing, and it provides genome-wide estimates of pre-mRNA synthesis rates comparable to those obtained via labeling
of newly synthesized RNA. We used SnapShot-Seq to investigate the origins of the intrinsic bimodality of metazoan gene
expression levels, and our results suggest that this bimodality is partly due to spillover of transcriptional activation from
highly expressed genes to their poorly expressed neighbors. SnapShot-Seq dramatically expands the information obtainable
from a standard RNA-Seq experiment.
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Introduction
The expression level of an individual mRNA species depends on
the rates of key events at three phases of its lifecycle: pre-mRNA
transcription, pre-mRNA processing, and mRNA degradation [1].
Each of these steps has the potential to be regulated to control
gene expression. Yet the dynamics and regulation of the mRNA
lifecycle in vivo are poorly characterized, limiting our ability to
understand the mechanisms by which gene expression is regulated
by chemical compounds, biological signals, or as-yet-uncharacter-
ized RNA-binding proteins, which may number in the thousands
[2].
The power of genome-wide approaches in defining key sites of
regulation has been demonstrated by recently developed methods
for quantifying the in vivo occupancy of RNA polymerase across
the entire genome [3–5]. Building on older single-gene studies [6],
these technologies have revealed that transcription is extensively
regulated beyond the initial step of RNA polymerase recruitment
to promoters [4,7]. However, the kinetics of other stages of the
mRNA lifecycle, such as splicing, are less understood. For
example, the estimated time required for splicing ranges from 30
seconds [8]to 12 minutes [9] in studies of individual introns [8–12]
_ENREF_10. It is unclear whether this variability reflects intron-
to-intron variation, species-to-species variation, or the differences
in the methods used. The ability to assess in vivo splicing rates
genome-wide could reveal new modes of gene regulation and
identify functions for the many putative splicing factors whose
functions remain unknown.
In this study, we describe a new method – SnapShot-Seq – for
quantifying mammalian mRNA dynamics, using only standard
RNA-Seq data that can be easily generated from any total cellular
RNA sample. We introduce a quantitative model that relates the
densities of total RNA sequencing (RNA-Seq) reads across exons,
introns, and splice junctions to the lifetimes of pre-mRNA
intermediate species and mature mRNAs. We describe experi-
mental tests of key assumptions of our method, as well as of its
ability to detect specific defects in transcription and splicing.
Finally, we apply our method to reveal that the intrinsic
bimodality of metazoan gene expression results from a bimodality
of mRNA synthesis rates, which in turn may result in part from
gene neighbor effects.
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Results
A quantitative model to measure lifetime from
abundance
Our goal was to develop a model that would allow us to
simultaneously determine the rates of each step in the mRNA
lifecycle solely from a single measurement of total RNA-Seq read
densities. A critical first step in this effort was based on the
observation that the number of RNA-Seq reads aligning to the 59
end of an intron is larger than the number of reads aligning to the
39 end. These decreases in apparent expression level are observed
in nascent RNA, nuclear RNA, and total RNA (Fig. 1A) [13–16].
We suspected that these decreases could be used to directly infer a
gene’s rate of pre-mRNA synthesis. This relationship between
decreases in expression level along the length of an intron and
synthesis rate could then anchor a model for determining the
lifetimes of a variety of mRNA intermediates.
We reasoned that the decrease in expression level across an
intron should be directly proportional to the number of RNA
polymerases transcribing the intron. This proportionality arises
because each polymerase actively transcribing the intron has
transcribed the 59 but not the 39 end of the intron (Fig. 1A).
Notably, the decrease in expression level across individual introns
does not translate into a decrease in intronic expression level along
genes, from one intron to the next. Instead, because introns can be
spliced and degraded as soon as they are transcribed, the pattern
of intronic expression along genes takes the form of a sawtooth
pattern [16]. The pre-mRNA synthesis rate should equal the
change in RNA-Seq read density across an intron, divided by the
time required to transcribe the intron (Tt, constant for a given
intron) and a constant c0 that relates read density to transcript
number per cell (Fig. 1A, Eq. 1; Materials and Methods).
In relating the pre-mRNA synthesis rate to the rate of intron
processing, we found it useful to consider the intronic expression
profile as an inverted guillotine blade with a rectangular base. The
height of the blade is proportional to the time required to
transcribe an intron (Tt; Fig. 1A–B, green) and depends solely on
the abundance of nascent introns. The height of the base is
proportional to the time required for intron processing (splicing
plus intron degradation, Tp; Fig. 1A–B, black) and depends solely
on the abundance of completely transcribed (but not yet degraded)
introns. The pre-mRNA synthesis rate affects the height of both
the base and blade proportionally, and therefore it does not affect
the ratio between these two measurements. Thus, the relative
times required for intron transcription and intron processing can
be inferred from the relative abundances of nascent introns (blade)
and completely transcribed introns (base) (Fig. 1A–B).
Building on this framework, we developed a full model relating
the times required for transcription and mRNA processing to the
abundances of introns and splice sites. For example in Eq. (2a)
(Fig. 1C), the 59 splice site of an intron is created by RNA
polymerase as it begins to transcribe the intron at time t=0; the
site exists during transcription of the intron (which lasts until time
Tt) and persists until the 59 splice site is cleaved to form the lariat
intermediate (which takes an additional time T5). Thus, the density
of RNA-Seq reads across the 59 splice site (D59SS) is proportional to
the total duration Tt + T5 and the pre-mRNA synthesis rate S. To
directly solve for the time required for lariat formation (T5), we can
substitute Eq. (1) into Eq. (2a), yielding Eq. (2b). Via a similar
procedure, the relationship between RNA-Seq read density and
time can be used to infer the times of exon ligation (T3) and intron
degradation (Tc) (Eqs. 3–4 in Fig. 1C) (Materials and Methods).
Given literature values for transcription elongation rate [11,17],
this set of equations can be solved to obtain the times T5, T3, Tc,
and the pre-mRNA synthesis rate (a general and detailed
treatment appears in Materials and Methods).
Caveats and limitations to the model
One potential caveat to our model is that the decrease in
expression level across introns could be caused in part by
exonucleolytic degradation of excised intron lariats (Fig. S1A–D).
To address the potential influence of lariat degradation, we
compared the decrease in expression level from 59 to 39 across
introns to the decrease between the 59 and 39 splice sites. Both the
intron and splice site decreases in expression level should be
influenced by the number of polymerases actively transcribing an
intron. However, because the splice sites are destroyed during
splicing, only the intron decrease should be sensitive to excised
lariat degradation (Fig. S1B–D). We performed total RNA-Seq on
HeLa cells using strand-specific sequencing of rRNA-depleted
total cellular RNA [18,19]. We observed that the decreases across
introns and splice sites were similar, suggesting that exonucleolytic
lariat degradation does not contribute to the shape of the intronic
expression profile (Fig. S1D–E).
A second caveat is that the intronic expression profile could also
be influenced by alternative splice isoforms (e.g., splicing of non-
consecutive exons or exon-skipping). To assess this possibility, we
quantified the expression levels of alternative splice isoforms. We
found that 97–99% of all exon-exon splice junction reads in HeLa
cells and mouse neurons were between consecutive annotated
exons (Fig. S1F). While apparently surprising, this result is
consistent with previous findings: although most genes are
alternatively spliced in at least one cell-type or tissue, most exon
splicing events do not involve alternative splicing [20]. In addition,
alternative splice forms tend to be tissue-specific and expressed at
lower levels than constitutive isoforms [21]. Thus on average it
appears that the contribution of alternatively spliced forms to the
total RNA population is fairly low. Nonetheless, we assessed each
of the different classes of alternative mRNA isoforms to determine
how each would affect our analysis of the intronic expression
profile and found that intronic expression profiles would be
minimally affected. (Materials and Methods).
A third caveat is that our model assumes that the rate of
transcription elongation is similar among introns and between
genes. This is a reasonable assumption on multi-kilobase length
scales [5,11]. On smaller length scales, and in particular near
promoters, the effects of pausing can be significant [22], so we
included in our analysis only introns larger than 5 kb that start
more than 5 kb from the transcription start site. Deviation from
linearity will also occur for a short period of time after gene
induction [15,22], but our model is only intended to be applicable
under steady-state conditions.
A significant limitation is that although our model should
eventually be applicable to individual genes, current datasets do
not enable single gene resolution. Instead, to overcome sequence
bias and counting noise, both of which can contribute significant
error when examining short RNA features such as individual 59
splice sites (Materials and Methods), it is necessary to average read
densities across multiple genes. Given currently available datasets,
therefore, our model can be used to produce average processing
times, and distributions of these times, for sets of multiple genes.
Applying SnapShot-Seq to obtain rates of pre-mRNA
processing
We used our model to determine mRNA processing times (T5,
T3, and Tc, as defined in Fig. 1C) for ten human tissues after
performing strand-specific total RNA-Seq [23] from ribosomal
RNA-depleted total RNA isolated from each tissue (Fig. 2A).
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PLOS ONE | www.plosone.org 2 February 2014 | Volume 9 | Issue 2 | e89673
Using a Monte Carlo approach, we repeatedly randomly sampled
sets of five genes and solved for the RNA processing times
(Materials and Methods), which produced a distribution for each
processing time. Across ten human tissues, we find lariat formation
(T5) takes an average of 1–2 minutes, exon ligation (T3) takes an
average of 30–70 seconds, and intron degradation (Tc) takes an
average of 20–30 seconds. These results are consistent with the
results of complementary techniques that have examined specific
steps in the mRNA lifecycle at small numbers of introns or genes
[8,11,24–26]. We also used our model to calculate mRNA
lifetimes (Tm). Across the same ten human tissues, the average
mRNA lifetime varied from just under 1 hour to nearly 4 hours
(Table S1 in File S1). These values are similar to the ,5 hour
average mRNA lifetime found by previous studies in mouse and
human samples [27].
To address the consistency of SnapShot-Seq across different
technological platforms, we performed total RNA sequencing from
HeLa cells while varying the library preparation method, the
ribosomal RNA removal method, and the sequencing platform.
We also addressed biological variability (Fig 2B). HeLa total RNA
Figure 1. A model for calculating mRNA dynamics from an RNA-Seq snapshot. (A) The decrease in expression from 59 to 39 along an intron,
shown as the height of the green ‘‘guillotine’’ blade, is a product of the rate of intron synthesis (S) and the time required to transcribe the intron (Tt).
The abundance of the fully transcribed intron at steady state, shown as the height of the black guillotine base, is a product of S and the intron
processing time (Tp). Tp consists of the two steps of splicing and intron degradation. Changes in S and Tp both affect total intron expression level;
however, only changes in S affect the difference in RNA-Seq read density across an intron. The conversion factor c0 has units of RNA-Seq read density
per initiated RNA transcript per cell. (B) A detailed timeline of pre-mRNA maturation indicating the four lifetimes (Tt, T5, T3, Tc) that can be inferred
from RNA-Seq read densities across three genomic features (INT, 59SS, 39SS). (C) Equations (2a) – (4) relating the times of lariat formation, exon
ligation, and intron degradation to total RNA-Seq read densities. Additional details are provided in the Materials and Methods section.
doi:10.1371/journal.pone.0089673.g001
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prepared using the dUTP-RiboZero method on the Illumina
platform [19] was consistent between biological samples, exper-
imental days, library preparation batches, and sequencing flow-
cells. We found a 2-fold increase in pre-mRNA processing times
when we directly compared the Illumina method to a double-
stranded ligation, RiboMinus-based method [23] (Whole Tran-
scriptome Sequencing) on the SOLiD platform (Fig. 2B). This
difference may reflect differences in the relative biases of these two
sample preparation strategies. While the absolute change in rates
was two-fold, the relative rate of each of the individual pre-mRNA
processing steps was consistent between platforms. To accurately
compare samples in subsequent experiments, we only compared
samples prepared in the same batch with the same sample
preparation pipeline.
Our results represent the first in vivo determination of the rates
of lariat formation, exon ligation, and excised lariat degradation
based on genome-wide data. From our full model, lariat formation
is 2–4 times slower than exon ligation and 4–6 times slower than
lariat degradation (Fig. 2A,B), suggesting that it is typically the
rate-limiting step in vivo. Lariat formation is similar to the average
time it would take to transcribe the next intron (,1.5 minutes for a
4.5 kb intron) and faster than the median time required to
complete transcription of the gene (,5 minutes), based on an
assumed average elongation rate of 3.6 kb per minute [11]. These
results imply that lariat formation frequently occurs before the
transcription of the subsequent intron is complete. Thus,
alternative splicing events such as exon skipping are likely to
require special mechanisms to prevent the conventional splicing of
consecutive exons during transcription of a subsequent intron.
SnapShot-Seq detects a global decrease in the rate of
lariat formation upon treatment of cells with the splicing
inhibitor isoginkgetin
To address whether our method could detect specific pertur-
bations in mRNA processing, we treated HeLa cells with the
splicing inhibitor isoginkgetin (30 mM), presumed to block splicing
by inhibiting the transition from spliceosomal complex A to B (i.e.,
tri-snRNP binding) [8,28]. We performed total RNA-seq on three
biological replicates of isoginkgetin-treated samples and their
paired controls. Consistent with the expectation that isoginkgetin
interferes with splicing, RNA-Seq data from isoginkgetin-treated
cells showed increased global expression of introns and splice
junctions relative to exons (Fig. 3A). The increases were not gene-
specific, as most or all expressed genes were affected (Fig. S2A).
These results are consistent with isoginkgetin-induced accumula-
tion of unspliced pre-mRNAs.
To measure the decrease in splicing rates caused by isogingke-
tin, we returned to the analysis described above (Fig. 1A). In the
intronic expression profile, the guillotine ‘‘blade’’ is derived from
nascent introns, and the ‘‘base’’ represents fully transcribed introns
that have not yet been degraded. If isoginkgetin were slowing
splicing, we should observe an increase in the height of the base.
As expected, the height of the base increases ,2.5-fold with
isoginkgetin treatment, indicating a 2.5-fold lower rate of splicing
(Fig. 3B). Absent any feedback of splicing inhibition on pre-mRNA
synthesis rates, the guillotine blade and intronic slope should
remain unchanged. Consistent with these predictions, there are no
detectable isoginkgetin-dependent changes in the guillotine blade
or intronic slope. Finally, the sawtooth pattern between adjacent
introns is still observed in isoginkgetin treated cells, as expected
unless splicing were 100% inhibited (Fig. S2B). These results
suggest that the intronic expression profile is a useful method for
assessing global splicing rates.
Because isoginkgetin is thought to block splicing before its first
catalytic step, we tested whether our full kinetic model would
detect a specific defect in lariat formation. With isoginkgetin
treatment, we observed a nearly two-fold increase in the time
required for lariat formation (Fig. 3C, T5), with no significant
effects on exon ligation (Fig. 3C, T3) or excised lariat degradation.
In total, these isoginkgetin-dependent changes in rates would be
expected to increase intron processing time (Tp) by ,2.5-fold,
consistent with our conclusions above (Fig. 3B). Our observation,
based on in vivo genome-wide data, that the rates of lariat
formation but not exon ligation are affected by isoginkgetin
accords well with the in vitro observation that isoginkgetin blocks
the formation of spliceosomal complex B.
Application of SnapShot-Seq to infer genome-wide rates
of mRNA synthesis and decay
As discussed above, current sequencing methodologies do not
support the application of our full model to individual genes.
Figure 2. SnapShot-Seq-derived timescales for ten human tissues and technical controls. (A) Lifetimes obtained from total RNA-Seq
performed on ten human tissues, using the SOLiD Whole Transcriptome Sequencing method [23] with RiboMinus rRNA-depletion. T5, T3, and Tc are as
defined as in Fig. 1. (B) A comparison of lifetimes across different sequencing methodologies. We performed sequencing on SOLiD (S) or Illumina (I);
hybridization-based rRNA depletion with RiboMinus (M) or RiboZero (Z); and compared RNA samples isolated and prepared into libraries on several
different days. We performed Illumina total RNA-Seq using the dUTP method [19]. Error bars indicate 95% confidence from Monte Carlo simulations
from individual biological samples.
doi:10.1371/journal.pone.0089673.g002
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However, we explored whether a simplified version of our model,
based on total RNA-Seq read densities in introns, could be
immediately useful for analysis of the synthesis and degradation
rates of individual mRNAs. One way to simplify the model might
be to use intron read density (DINT) as a proxy for pre-mRNA
synthesis rate and to calculate the degradation rate by dividing the
mRNA abundance by the synthesis rate. The assumption that
DINT can act as a proxy for synthesis rate has been made before
[29], but has not been validated theoretically or experimentally.
As seen in Eq. (5) (Fig 4A), a caveat to using DINT to estimate
mRNA synthesis rate is that intron expression is dependent not
only on the mRNA synthesis rate but also on the intron processing
time (Tp) and intron length (which affects the intron transcription
time, Tt). Using DINT as a proxy for synthesis rates would
therefore introduce a significant bias. Specifically, this bias could
result in an artifactual correlation between gene length and
synthesis rate [30], since longer genes tend to have longer introns,
and the read density of long introns is inflated by the longer time it
takes to transcribe the intron. To avoid this bias, we estimated the
synthesis rate of each gene using the average total RNA-Seq read
density of the 39-most 10 kb of each of its introns (D39INT, derived
from the entire intron for introns shorter than 10 kb). On this
10 kb length scale, the contribution of Tt/2 (,80 seconds, based
on 3.6 kb/min [11]) is less than Tp (,3.5 minutes, sum of times
from Fig. 2A), and the influence of intron length is negligible
(Fig. 4A, Eq. 6). While sequences shorter than 10 kb could be used
to further minimize the contribution of Tt, in this case each intron
would be represented by fewer reads. Our strategy balances the
benefits of the increased accuracy of quantifying expression using
longer sequences while minimizing the length-dependent inflation
of intron density.
Using D39INT as a proxy for pre-mRNA synthesis rate minimizes
the bias caused by intron length, but the apparent synthesis rate
based on D39INT still depends on the relative processing times of
each intron (Tp in Fig. 4A, Eq 6). Therefore, for this proxy to be
useful, the variation in mRNA synthesis rates (S) must be much
larger than the variation in intron processing times (Tp). A
maximal bound on the variation in Tp can be directly assessed by
comparing D39INT for introns from the same gene (Fig. 4B). Intron
levels in a single gene are set by S?Tp, with S constant for all
introns synthesized from a common promoter. In contrast,
variation in mRNA synthesis rate can be assessed by comparing
introns from different genes. Variation in intron levels between
genes again depends on S?Tp, but now S is not constant (Fig. 4B).
We found that the intergenic variation in D39INT was at least an
order of magnitude larger than the intragenic variation in D39INT
(Fig. 4C). Thus, D39INT is a reliable proxy for relative mRNA
synthesis rate and is influenced comparatively little by intron
processing rates (Fig. 4A, Eq 7). This method is practical for single
gene measurements because D39INT is easy to measure accurately
using total RNA-Seq. In further support of our analysis, we found
that D39INT is directly proportional to intronic slope, another
measure of synthesis rate (Figs. S3A,B).
To independently assess the accuracy of using D39INT as a proxy
for mRNA synthesis rates, we performed sequencing of newly
synthesized RNA using 4-thiouridine (4SU) labeling [30–32]. We
compared our estimate of mRNA synthesis rates based on D39INT
from total RNA-Seq to estimates of mRNA synthesis rates based
on quantification of newly synthesized 4SU-labeled RNA.
Estimates of synthesis rates from the two methods were linearly
correlated (Spearman’s r=0.87, Fig. 4D), unlike 4SU-labeled
RNA and total RNA-Seq exon densities (Figs. S3C).
Together, accurate measurements of mRNA levels and
synthesis rates can be used to estimate mRNA lifetimes for
individual genes (Fig 5A). Our estimates of mRNA lifetime varied
significantly among genes, in agreement with mRNA half-life
estimates ranging from 16 minutes to 790 minutes for inducible
transcripts [33]. Similarly, high-throughput estimates of mRNA
turnover from 4SU-labeled RNA experiments reveal distributions
of mRNA turnover rates shaped similarly to our own, with our
method having a 5-fold larger full-width at half-max [27]. This
larger variance in mRNA lifetimes between genes in our method
could result from biological differences, from biases due to the sets
of genes examined, or from or the techniques themselves. Overall,
these comparisons show that measurements of D39INT can be a
Figure 3. The rate of lariat formation is decreased two-fold by isoginkgetin treatment. (A) Genome-wide expression of 59 splice sites, 39
splice sites, and introns are increased relative to exons upon treatment of HeLa cells with isoginkgetin (30 mM, 18 hours), based on total RNA-Seq
(dUTP method [18], Illumina). The height of each bar indicates the fold change, from vehicle- to isoginkgetin-treated cells, in the mean fraction of
reads aligning to each genic feature (p,0.02 from two-tailed t-tests for all ratios). (B) Isoginkgetin treatment increases the ‘‘guillotine’’ base height
(p=10212) of intronic expression without increasing the blade height (p= 0.5), consistent with a splicing defect (compare to Fig. 1A). Only introns
longer than 50 kb from genes with at least 10 introns are included in these meta-intron profiles, which show the last 50 kb of each aggregated intron.
Introns of different lengths are aligned at their 39 ends. RNA-Seq density is normalized as read counts per 10M uniquely aligning reads. The indicated
values are from an average of three biological replicates, and p-values are from two-tailed t-tests based on mean values for aggregated introns 2–10
(n = 9). (C) Isoginkgetin treatment leads to a decreased rate of lariat formation (* indicates p=0.02) without affecting exon ligation or excised lariat
degradation (p= 0.22, 0.08), with calculations as in Fig. 1. p-values are from two-tailed t-tests with n = 3 biological replicates. Error bars in (A, C)
represent s.e.m. from three biological replicates.
doi:10.1371/journal.pone.0089673.g003
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powerful method for extracting mRNA synthesis and decay rates
from easily obtainable total RNA-Seq data.
Bimodality of gene expression reflects genome
organization
We applied our ability to assess genome-wide rates of mRNA
synthesis and decay to investigate the poorly understood
phenomenon of gene expression bimodality. In metazoans,
expressed genes fall into one of two categories: a, ,1 mRNA
per cell (low) mode or a . ,1 mRNA per cell (high) mode [34].
We asked whether this bimodality could be cleanly attributed
either to mRNA synthesis or degradation. Using D39INT to assess
synthesis rates, we observed a bimodal distribution of synthesis
rates, but not of mRNA stabilities, in a variety of tissues and cells
(Figs. 5A, S4A,C–E), strongly suggesting that pre-mRNA synthesis
rates are the sole determinant of the observed bimodality. This
interpretation is supported by the fact that genes segmented into
high and low expression levels are simultaneously segmented into
high and low mRNA synthesis rates respectively (Fig. S4B).
We asked whether low mode genes and high mode genes fall
into distinct functional categories. Using RNA-Seq data from
mouse neurons or HeLa cells, low mode genes specifically are
enriched for gene ontology (GO) categories associated with
membrane and extracellular compartments (Table S2). These
same categories are also enriched among tissue-specific genes
(those expressed in only 1-2 of the 10 human tissues we examined).
This extensive set of shared categories suggests that the low mode
of expression may simply reflect incomplete repression of genes
that are not needed in the tissue of question, rather than a need for
very low levels of the product of these genes. Supporting this
hypothesis, unexpressed genes are similarly enriched for GO
categories associated with membrane and extracellular compart-
ments (Table S2).
We therefore sought to identify a mechanism that could explain
why some genes are expressed in the low mode while others are
not detectably expressed. One cause of the low expression mode
could be the presence of nearby genes that are highly expressed.
Neighboring genes are more likely to be co-expressed and co-
regulated in a variety of organisms including S. cerevisae [35–38],
C. elegans [39], and humans [39,40]. To investigate whether the
low expression level of some genes could result from their genomic
proximity to highly expressed genes, we examined the distances
Figure 4. Average expression of the 39 ends of introns across a gene is an accurate measure of mRNA synthesis rate. (A) Equations
relating the mRNA synthesis rate S to RNA-Seq density across introns (DINT) or across the 39 ends of introns (D39INT). Tp is intron processing time, and c0
is a constant relating RNA-Seq read density to transcript number per cell. In Eq. (7), subscripts 1-2 and superscripts 1-2 refer to separate genes. (B) The
expression levels of the 39 ends of introns are a useful proxy for mRNA synthesis rates, assuming that the variation in intron processing times among
introns is smaller than the variation in mRNA synthesis rates among genes. The schematic shows the contributions of mRNA synthesis and intron
processing to expression at the 39 ends of introns across two hypothetical genes, each with three introns. The second gene is transcribed at a higher
rate. (C) The assumption stated in (B) holds true: the within-gene standard error of intron densities at the 39 ends of the (D39INT, red) is much smaller
than the range of average D39INT among genes (blue). For clarity, the distribution of standard errors of D39INT is shown for the subset of genes with
mean intron log-densities within 10% of -5 on the x-axis. Data is from mouse neuron RNA-Seq using SOLiD. (D) Quantification of mRNA synthesis
using RNA labeling with 4-thiouridine (4SU, vertical axis) versus total RNA-Seq (D39INT, horizontal axis). The two methods are correlated with a
Spearman’s r of 0.87. Each point represents one gene and is an average of three total RNA-Seq and three 4SU RNA-Seq samples (biological replicates)
from a lymphocyte cell line. Cells were exposed to 4SU for five minutes before cell lysis. Sequencing was performed using the dUTP/Illumina method
(total RNA) or standard Illumina RNA-Seq (4SU).
doi:10.1371/journal.pone.0089673.g004
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from genes in the unexpressed, low, and high modes to the nearest
high mode gene. We found that low mode genes are far more
likely than unexpressed genes to be within 100 kb of a high mode
gene (Fig. 5B). This effect occurs both for tail-to-tail and head-to-
tail gene pair architectures, indicating that the effect cannot be
attributed solely to shared, bidirectional promoters or to
transcriptional read-through (Fig. 5C). To evaluate the extent of
this potential effect, we considered what happens when a low-
expressed gene in one tissue converts to an unexpressed gene in a
different tissue. In these cases, the distance to the nearest high-
expressed gene increases 45% of the time, compared to a 27%
chance expectation (Fig. 5D). The magnitude of this effect suggests
the hypothesis that at least 15% of the low expressors are
expressed only because of their genomic proximity to high
expressors. The strand-independence of these gene neighbor
effects suggests that they could be mediated by long-range
chromatin interactions, such as DNA looping.
Discussion
We have developed a new computational method, SnapShot-
Seq, for measuring the dynamics of RNA production and
processing. The method relies on the fact that the abundances
of intermediate RNA species are proportional to their lifetimes.
Relying on this proportionality, it is possible using only standard
total RNA-Seq data to: derive rates of pre-mRNA synthesis and
timescales for specific pre-mRNA processing steps (Fig. 1), detect
in vivo alterations in the rates of specific steps of splicing (Fig. 3),
and obtain genome-wide measurements of mRNA synthesis and
degradation rates (Fig. 4). Our approach has several advantages
over the existing state-of-the-art methods. First, it requires only
standard RNA-Seq data and can thus be performed post hoc on
existing total RNA-Seq data sets. Second, it does not require any
of the perturbations previously needed to determine kinetics of
splicing and mRNA degradation, e.g., cellular uptake of a
chemical label [41] or interference with RNA polymerase II
Figure 5. Bimodality of mRNA synthesis rates reflects genome organization. (A) Distributions of gene expression levels (DEXN), mRNA
synthesis rates (D39INT), and mRNA stability (DEXN/D39INT) reveal two modes of gene expression. DEXN and D39INT refer to the RNA-Seq read densities
across exons and the 39-most 10 kb of introns respectively. (B) Compared to genes that are not expressed, low and high expressors are found closer
to highly expressed genes. The x-axis indicates the distance from a gene’s transcription start site (TSS) to the TSS of the nearest high expressor; *
indicates p,1023 by a two-sample K-S test. (C) Genes adjacent to high mode genes are disproportionately more likely to be in the low mode and less
likely to be in the off mode of gene expression, for both head-to-tail and tail-to-tail gene pair architectures (* indicates p,1026 from a bootstrap
simulation with one million iterations, in which expression classes were permuted). (D) Between tissues, when genes transition from low expressors
to non-expressors, their average distance to the nearest high expressor increases (p,2.2610216, based on a chi-square test). The ,15% difference
between the data and the randomized control suggests that at least 15% of the changes from low to off are due to a nearby gene being up-
regulated. RNA-Seq data is from mouse cortical neurons sequenced using SOLiD [53] (A–C) and ten human tissues (D).
doi:10.1371/journal.pone.0089673.g005
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[11,42–44]. Nor does our method require immunoprecipitation
[5] or rely on in vitro enzymatic activity [4]. Unlike many
competing methods, our method is easily applied to whole tissues,
including quantity-limited diseased and normal tissue biopsies
from patients. Our method should prove informative for
examining splicing rates in diseases – such as retinitis pigmentosa,
myelodysplastic syndrome, and lymphocytic leukemia – whose
etiologies involve RNA processing defects that remain poorly
understood [45–48]. Finally, our method is unique in simulta-
neously assessing many aspects of mRNA dynamics, an advantage
that could prove useful in understanding the interconnections
among different steps in pre-mRNA processing.
Our current SnapShot-Seq analyses rely in many cases on
average abundances across multiple introns in order to precisely
compute the intron slopes and splice site read densities that are
crucial inputs to our dynamical model. As sequencing technologies
and library preparation methods improve, SnapShot-Seq will
allow the dynamics of each step of splicing to be precisely
determined for individual genes and individual introns (Materials
and Methods). Eventually, increased sequencing read depth and
reduced bias should provide accurate read densities at single-
nucleotide resolution, making it possible to extend our method to
measure nucleotide-by-nucleotide RNA polymerization rates.
Even at current sequencing depths, applying our method to assess
the results of a larger set of pharmacological and genetic
manipulations of pre-mRNA processing factors will likely reveal
new mechanisms of pre-mRNA processing and clarify intercon-
nections between the stages of the mRNA lifecycle.
Materials and Methods
Accession numbers
We performed both SOLiD and Illumina RNA sequencing,
available under GEO accession number GSE48889. We also rely
on previously published data from GSE21161.
Cell culture and sample preparation
RNA sources. Human tissue RNA-Seq was performed on
total RNA from the Ambion FirstChoice Human total RNA
Survey Panel. HeLa RNA-Seq was performed on HeLa total RNA
isolated from HeLa cells (sequenced on Illumina for the IsoG
experiments) or purchased from Ambion (cat # AM7852,
sequenced on SOLiD). Mouse cortical neuron RNA-Seq data
was taken from previously published work, where E16.5 mouse
cortical neurons from C57B6 mice were cultured for seven days in
vitro before isolating RNA [49]. Our human tissue analysis is IRB
exempt because RNA samples were purchased as de-identified
samples.
HeLA cell culture, RNA extraction, and qRT-PCR. HeLa
cells were obtained from ATCC and were not authenticated for
this study. Hela cells were maintained in DMEM supplemented
with 10% fetal bovine serum, 1% Penicillin-Streptomycin, 1%
non-essential amino acids. Cells were plated to about 70%
confluence the day before any drug treatments on 10 cm plates.
Cells were treated overnight with 30 uM Isoginketin (IsoG,
Millipore) for 18 hours. For RNA extraction, cells were washed
1x with PBS then lysed with RLT buffer. Samples were
immediately processed with Qiashreddar and RNeasy kits
(Qiagen) and frozen until further use. 9 ug of RNA was DNAse
treated and cleaned up with RNeasy Minelute kit (Qiagen). RNA
quality was assessed by Bioanalyzer (Agilent) and all samples had
RINs of 9.0 or higher.
Isolation of newly synthesized transcripts using 4SU
labeling. Newly synthesized transcripts were isolated using
modified methods previously described [32,50–52]. Briefly,
lymphoblastoid cells were pulse-labeled with 200 mM of 4-
thiouridine (4SU) for 5 minutes. Cells labeled in DMSO (without
4SU) served as negative controls. Following incubation in 4SU,
cells were harvested by centrifugation and RNA extracted using
Trizol (Invitrogen). Extracted RNA was further purified using
RNeasy columns (Qiagen) and eluted to a concentration .0.4 ng/
ml. Purified RNA was denatured, and the 4SU-incorporated sites
were biotinylated using 1 mg/ml EZ-link biotin-HPDP [52] by
incubating at 65uC for 1.5 hours and then 25uC for an additional
1.5 hours. Unincorporated biotin-HPDP was removed twice using
chloroform-isoamyl alcohol (24:1) and centrifuging the mixture in
phase-lock-gel tubes (Eppendorf) as described [51]. Biotinylated
RNA was captured and purified using MyOne streptavidin C1
beads (Invitrogen) and eluted in 5% b-mercaptoethanol as
described [52]. RNA-seq libraries were constructed using TruSeq
library preparations (Illumina).
Sequencing library preparation
Illumina library construction and sequencing. RNA-seq
libraries were constructed using the strand specific dUTP method
[18], with minor modifications. Briefly, 3 ug of DNAse treated
RNA was depleted of rRNA using Ribozero (Epicentre). Two
batches of rRNA-depleted samples were combined, cleaned by
RiboMinus concentration module (Invitrogen) and fragmented at
90uC for 3 min (NEB fragmentation buffer). First strand synthesis
was followed by cleanup with RNAClean XP SPRI beads
(Agencourt). Second strand synthesis incorporated dUTP, fol-
lowed by sample clean up with MinElute PCR purification Kit
(Qiagen). Fragment ends were repaired, adenylated, then ligated
to True-Seq barcoded adaptors and cleaned up with AMPure XP
SPRI beads (Agencourt). The libraries were then amplified by
PCR for 12 cycles and cleaned up with AMPure XP SPRI beads.
Illumina sequencing (1650 bp read length) was performed on a
HiSeq 2000. 4SU libraries were prepared non-strand-specifically
using standard Illumina RNA-Seq.
SOLiD RNA-Seq library construction and
sequencing. Total RNA was depleted of ribosomal RNA by
hybridization using RiboMinus (Invitrogen) and was heat-
fragmented, end-repaired with T4 PNK, and processed into
SOLiD sequencing libraries using the double-stranded RNA
ligation method in the Small RNA Expression Kit. Sequencing
was performed on SOLiD with 35 bp (human tissues, mouse
neurons) or 50 bp (HeLa) read lengths.
Sequencing methods and sample list
Sequencing was performed on SOLiD using SOLiD V2
chemistry with 35 bp (human tissues) or 50 bp (HeLa) read
lengths. The number of aligned reads is indicated in Table S3 in
File S1.
Summary of SnapShot-Seq model of mRNA processing
times
Fitting the model relating mRNA processing times to
densities of RNA-Seq reads. With 5 unknowns and 6
equations, our model does not have full rank. But in solving the
model for individual genes, noise in the measurements leads to
nonsensical solutions — i.e., negative values for timescales — for
many of the genes. Based on results from simulations, we
developed two methods that reliably give timescales even with
noisy experimental data. In one method, we add noise to empirical
read densities and slopes used to fit the model, under the
assumption that our data have noise and their ‘‘true’’ values lie
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within the noise of our experimental value. We repeatedly solve
the model, each time adding random noise based on experimental
error to the data. We keep only those solutions having all positive
timescales; upon many trials, the resulting distributions for the four
processing times acquire well-defined ranges. This approach does
not work for every individual intron or gene, so we employed for
all figures shown a second, Monte Carlo method, whereby we
aggregated the observed slopes and feature densities from random
subsets of about 4,000 genes that were appropriately pre-filtered
(for expression level and . 5 kb length). Samples of five genes
were picked at random and, based on their aggregated slopes and
densities, timescales were calculated by solving the model. This
was repeated for each tissue or cell type until at least 2,000
solutions with all-positive timescales were found.
Bioinformatics pipeline overview
Sequence alignment. SOLiD reads were aligned in color-
space using Corona (formerly Applied Biosystems, now Life
Technologies), allowing for 0–3 or 0–5 colorspace mismatches
(35 bp and 50 bp respectively). Illumina reads were aligned using
BWA. In each case reads were aligned to the human or mouse
genomes, plus a library of species-specific splice junctions
constructed from all possible splices among annotated exons.
Overview of bioinformatics pipeline. After sequence
alignment, RNA-Seq reads were processed using custom perl,
MATLAB, and R scripts. For all analysis of RNA-Seq data by
genic features, RNA-Seq data was processed by MAPtoFeatures,
described below.
Assigning RNA-Seq reads to genic features using
MAPtoFeatures
MAPtoFeatures is a collection of custom-built perl scripts for
assigning RNA-Seq reads to genomic features based on a given
annotation. There are a number of scripts used for this work that
are available upon email request. The approach is gene-centered,
so alternative transcripts are merged into a representative ‘‘Gene’’
whose features include exons (coding and noncoding), introns, and
their junctions (both before and after splicing). Reads are of fixed
length (e.g., 35 bp, 50 bp) and strand-specific. The principal input
files include (1) one or more Reads files, (2) a Features file, and, if
available, (3) a splice library key file and (4) mappability-index files.
The Reads file contains reads that have been mapped uniquely in
a strand-specific manner to a genomic locus (chromosome and
coordinate) or splice library. For this study, features are based on
NCBI’s RefSeq for mouse 37.1 or human 37.1 with exonic
coordinates for annotated transcripts, namely, chromosome,
strand, and locus for individual UTRs and coding exons. For
each gene, reads will be assigned to the following feature
categories: UTR5, UTR3, CDS (and their union, EXN), and
INT; their loci are given in the Features file. Additional features
that span the junctions between other features are defined to
capture any reads crossing specific boundaries. These junction
features include exon-intron (JXN5) and intron-exon (JXN3) splice
sites and all possible intragenic exon-exon splice junctions (SPL)
based on the given annotation. Existence of alternative transcrip-
tion — alternative exon lengths or alternate transcriptional start
sites — can obscure some features. When ambiguity exists reads
are mapped to exons, e.g., if a read is mapped to the sequence for
an intron in one splice variant and to an overlapping exon in
another variant, the read will be assigned to the exon. The Splice
library key file annotates a pseudochromosome comprising every
potential splice variant between two or more exons in a gene, each
with minimal sequence for the junction(s) to be spanned by reads.
Splice variants were derived from 27,854 RefSeq transcripts in the
mouse 37.1 genome, producing 2,197,375 distinct potential splices
mappable with 35-bp reads; for the human 37.1 genome, 29,149
transcripts were used to produce 2,318,291 splices. Not every
feature of a gene is perfectly mappable. Mappability indices, which
allow one to compensate for differences in the ability to map
random reads to each feature, are created by attempting to map
every potential read against all features in the Features file and
splice library. In total, about 85% of EXN, 75% of INT, 60% of
SPL, and 80% of JXN5 and JXN3 features are mappable with
35 bp colorspace (SOLiD) reads. The read density (coverage per
target base) can then be adjusted in total or on a feature-by-feature
basis to correct for mappability. Features, Reads, and splice key
files can then be used to calculate the number of reads overlapping
each feature of a gene. To be able to directly compare between
different sequence runs, which can contain different total reads or
different read lengths, read densities are renormalized for a
standard total 10 million reads of length 35 bp. To obtain
normalized reads densities in units of rpkm, divide our density
values by 0.35.
Determining the slope in intron density, and filtering
methods
To determine the slope in intronic density, each intron was
divided into 100 bins of equal sequence length, and the reads were
distributed into these bins based on sequence alignment. Linear
least-squared regression was used to calculate the slope of this line.
Segmenting an intron into bins does not affect the calculation of
slopes as compared to directly calculating a slope from the read
density across a full intron. It also allows us to assess if there are
aberrant regions of an intron. Accordingly, introns with spikes
(often from non-coding RNA) were removed; introns whose slopes
have high error were also removed.
Read depth, counting noise, and accuracy of our model
As noted in the manuscript, our method is not applicable at
single introns. We wished to determine whether this limitation was
due to counting noise or technical biases. Furthermore we wished
to understand the increase in read depth necessary to allow our
model to be used at single intron resolution if other biases were
eliminated. To calculate the expected error in our model we used
Monte Carlo simulations of introns of varying lengths, with
different RNA processing time scales, and different read depths. At
our current average read depth, we should be able to detect intron
densities, exon densities, and introns slope with 25% error for
introns longer than 1 kb and a 1 minute intron degradation time.
This error goes up to 160% if the intron processing time goes to 10
minutes, and drops to 8% error at intron processing times of 6
seconds. Increasing the intron to 10 kb drops the error to 7%
while an intron of 100 bp increases the error to 80%. As our
experimental error is significantly larger than these estimates, bias
is a major limitation in our method and highlights the need for
improvements in library preparation and sequence methodologies.
For splice site quantification, while biases probably also exist,
measurement of 59 and 39 splice sites are limited by counting noise.
In order to achieve single intron resolution rates for the first and
second step of splicing at 25% accuracy we would need
approximately 50-fold more sequencing depth.
Assessing the potential impact of alternative splicing on
the calculation of timescales
Our model (Fig. 1 and Eq. 21) assumes that each intron is
spliced independently, with splicing being possible as soon as all
the needed intron features (59SS and 39SS) are transcribed. This
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situation is complicated by the fact that there are multiple
mechanisms of alternative splicing which break this assumption.
We sought to understand the potential impact of alternative
splicing and other kinds of mRNA isoform diversity on our ability
to calculate the timescales for each of the steps of mRNA
processing. We thus assessed the frequency and potential impact of
a variety of alternative isoforms, taken from the literature [20]:
1. Skipped exons. We cannot accurately filter skipped exons
out of our analysis, but according to our analysis of exon junction
RNA-Seq reads, only ,2% of exon junctions detected in total
RNA correspond to skipped exons (Fig. S1F), limiting the effect of
skipped exons on our lifetimes to 2%. Skipped exons will increase
the 59SS, 39SS, and intron density and thereby the apparent
lifetime of each feature by the same amount – namely the time
required to transcribed the skipped exon and the following intron.
The exonic density and splice junctions will decrease. While, in
theory, T5 is included in equation 21e, in practice Tm dominates
this equation, as it is the longest times scale. Hence, the change
cause by skipped exons can be lumped total into the T5 – this is the
term shared between equations 2–4. This makes intuitive sense in
that a delay in splice will also add the same amount of density to
the 59 SS, 39SS and intron. Importantly, this means that our
calculation for T5 is an upper bound on the rate. The decrease in
Tm should be minimal as only a small portion of a gene’s exonic
density comes from any one exon.
2. Alternative 59 or 39 SS. There are two scenarios: one
where the alternative splice-site shortens the intron, and one where
it lengths in the intron. When the intron is lengthened, the exon
density will decrease slightly (because it is degraded with the
intron) and the 59 or 39SS will increase slightly as they will now live
as long as the intron. 59 alternative splice sites will result in a slight
over-estimate of synthesis rates and an underestimate of T3 and
Tc. 39 alternative splice sites will result in T3 being over estimated
and Tc being underestimated. If the intron is shorter than
expected the 59SS and 39SS will become part of the intron leading
to significantly higher density and the potentially to greatly
overestimate the T5 and T3. Luckily, shorter introns can be filtered
out as it causes the 59SS and 39SS density to increase from a level
that is similar to the intronic read density to a level that is similar
to the exonic read density.
3. Unannotated alternative first/last exon. These events
should have no effect on our model because we treat each intron
or splice unit independently.
4. Unannotated tandem 39 UTRs won’t affect our model,
since they are found outside the genic regions we consider.
5. Mutually exclusive exons are a special case of skipped
exons and will have them same effects on rate calculations as
skipped exons.
6. Retained introns are relatively rare [20]and would behave
similarly to skipped exons except that the increase in signal is now
large as it depends on the lifetime of the mRNA as opposed to the
time required for alternative splicing. This could lead to a major
over-estimate of T5, but again, we can filter out retained introns as
it causes the 59SS and 39SS density to increase from a level that is
similar to the intronic read density to a level that is similar to the
exonic read density.
In summary, most alternative splicing can be either ignored, as
it doesn’t affect our model (e.g. unannotated first exons), or can be
filtered out because of its observable effect on read density (e.g.
retained introns). The remaining alternative splicing events (e.g.,
skipped exons) affect our model but do this by causing us to
overestimate T5 or slightly underestimate Tm. As T5 is already
relatively low, the fact that alternative splicing serves as an upper-
bound gives increased confidence that the true value is at most the
value we calculate. While our Tm could be an underestimate, the
amount of decrease in this rate should be proportional to the
frequency of skipped exons which is a relative small portion of total
exonic counts (Fig. S1F) [20].
The SnapShot-Seq model relating mRNA processing
times to densities of RNA-Seq reads across genic features
Our model of the eukaryotic mRNA life cycle aims to extract
dynamical information about RNA transcription, processing and
degradation from a single pool of RNA-Seq reads. The organizing
assumption of this model — that the biological sample, or samples,
from which the reads are derived has attained a steady state with
respect to these processes — allows us to assert that all species of
nascent, premature, or mature RNA and their derivatives are
present in the RNA-Seq library in direct proportion to their mean
lifetimes in the cells from which they were obtained. Thus, if we
know relative abundances of the different RNA species that arise
in our model, we should conversely be able to infer RNA-
processing lifetimes from experimentally determined feature
abundances. Equivalently, specific genomic features such as
introns, exons, and their junctions acquire different relative
abundances in the various stages of RNA processing and so allow
us to predict lifetimes from genomic locus-specific RNA-Seq data.
Our model is based on the following assumptions about the
structure, creation, splicing, and degradation of mRNA tran-
scripts:
– Each gene comprises N+1 exons separated by N introns (N$0),
whose lengths are all arbitrary, unless otherwise indicated.
– Transcription of each gene g is initiated randomly at a fixed
rate of Sg transcripts per second. This rate is independent of
how long the polymerase complex might have been ‘‘loaded’’
at the transcriptional start site. Once begun at the 59-most
exon, transcription proceeds uniformly and continuously
through all features at an average, transcript-independent rate
a= 3.6 kb/min, i.e., with a characteristic time constant
Ta=1/a=1 sec per 60 bp. If transcriptional pausing occurs,
we assume that it arises randomly throughout the transcript
and effectively lowers the value of a; pausing that preferentially
occurs at specific features, e.g., at the beginning of exons, can
in principle be identified as a consistent kink in the differential
slope across those features. Transcription terminates when the
polymerase reaches the 39 end of the 39-most exon — we
ignore details concerning the transcript’s 59 cap and polyA tail.
– Splicing out of each intron takes place in two steps, each with
its own characteristic time. (1) Lariat formation occurs at a time
T5 after the polymerase has transcribed the 39 end of the
intron; at that time the 59 splice site (59SS) between the intron
and its upstream exon is cleaved and hence the junction feature
there is destroyed. (2) Exon-exon splicing is completed at a time
T3 after lariat formation, whereby the 39 splice site (39SS)
between the intron and its downstream exon is cleaved, that
junction feature is destroyed, and the adjacent exons are ligated
together. We assume for now that these two events simply cut
the first and last bases in the intron from their neighboring
exonic bases but that the entire intron remains accessible to
RNA-Seq. This standard model of splicing assumes that
transcription proceeds apace, without locus-specific pausing,
even during the time T5+T3 these splicing steps are carried out.
As a result, each intron is spliced out in sequence but
independently. Once an intron has been removed, it is
assumed to persist in the sample for a further length of time
Tc, at which point it is degraded and no longer detectable. We
ignore alternative splicing here; our data suggest that, although
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some exons may be occasionally skipped in most genes, only
2% of all splicing events involve nonadjacent exons (not
shown).
– The lifetime of a mature mRNA transcript is taken to begin as
soon as the 39-most pair of exons have been ligated following
intron excision. The mRNA is assumed to exist, and all of its
constituent exons to be detectable, for a time Tm, after which it
is considered degraded and undetectable.
– Excised lariat degradation does not contribute to the intron
expression profile. Although this assumption is consistent with
the observations in Fig. S1, the precise mechanism of excised
lariat degradation is unknown, and these observations do not
rule out every possible contribution of lariat degradation to the
intron expression profile.
From this model we can predict the duration of every single
transcribed base, from the primary transcript’s synthesis until the
introns’ and mature transcript’s degradation. The abundances of
bases at individual loci or throughout genomic regions are
quantified here by their relative coverage by RNA-Seq reads of
length r. The times {T5, T3, Tc, Tm} and synthesis rates Sg are to
be determined.
For purposes of illustration, we begin by assuming that a
transcript has N+1$2 exons of equal length L and N$1
intervening introns of equal length L..1. Consider first the fate
of any one of the introns. After transcription brings into existence
the RNA bases at its 59 end, those bases will continue to exist as
part of nascent transcripts while the remainder of that intron
continues to be transcribed, for some duration Tt. They further
persist throughout intron processing — during the two stages of
splicing and until the whole intron has been degraded, i.e., with an
additional duration equal to the total processing time
Tp =T5+T3+Tc. Bases near the 39 end, on the other hand, are
created at the termination of the transcription ‘‘clock’’ and so
endure only for the time Tp following transcription. In general, a
base located at a distance x from the intron’s 59 end (0#x,L) has
a ‘‘transcription waiting time’’ Tt,INT(x) = Ta(L–x) during which
it is part of some nascent transcript in which that intron has not yet
been completely transcribed. The total duration of such an
intronic base is
tINT(x)~Tt,INT(x)zTp~Ta L{xð ÞzT5zT3zTc ð1Þ
The abundance of this base in a real sample will be proportional
to this total time — derived for a single transcript — times the rate
Sg at which transcripts were initiated in the sample. The number
of such bases therefore equals tINT(x)?Sg. We quantify feature
abundances from RNA-Seq data with single-base resolution in
terms of reads ‘‘Density’’ D (see the Methods section on
MAPtoFeatures). Since this quantity depends on the concentration
of total RNA in the sample, depth of RNA sequencing, and
normalization of total reads number, we must introduce a sample-
specific proportionality constant c0 (units Density per transcript
base counted) to rescale the relative abundances of all features
measured in the same sample to Densities:
DINT(x)~c0:Sg:tINT(x)~c0:Sg ½Ta(L{x)zT5zT3zTc ð2Þ
The Density of reads over the entire intron follows from
averaging Eq. (2) over all x:
DINT~c0:Sg:tINT~c0:Sg ½Tt,INTzT5zT3zTc,
Tt,INT~
1
2
TaL
ð3Þ
where tINT is the average duration of intronic bases. Note that
Tt,INT, the average transcription waiting time for all bases in the
intron, employs half its length. This result applies to every
individual intron of length L. Moreover, the average Density over
all intronic bases in the gene is trivially the same in this case,
because all introns have the same length. The change in Density
per unit length across each intron is given by the slope
SlopeINT~dDINT=dx~{c0
:Sg:Ta ð4Þ
which offers a direct readout of a gene’s relative mRNA synthesis
rate. (As a rule of thumb, for each gene g, the value 3600?|Slopeg|
gives c0Sg in units of normalized Density accumulated per minute
of feature duration.) In this model, the Density in an intron always
falls from its 59 to its 39 end, at a constant rate.
Junctions between exons and introns, the 59SS and 39SS
features, behave similarly to the introns’ ends except they do not
last until intron degradation. Each intron’s 59 splice site is created
as soon as transcription of the intron begins, waits a time TaL for
the entire intron’s transcription, and then disappears at the first
splicing step, after time T5, so its total duration is t59SS = TaL+T5.
Its 39 splice site is instead created after the intron’s transcription
and is destroyed after t39SS = T5+T3, the time it takes for both
splicing steps. The associated Densities are
D50SS~c0:Sg:t50SS~c0:Sg ½Tt,50SSzT5, Tt,50SS~TaL ð5Þ
D30SS~c0:Sg:t30SS~c0:Sg ½T5zT3 ð6Þ
These expressions relate the abundance of reads that cross
either splice site to the lifetimes of these junctions. If all splice-site
features in the genome can be regarded as having equal length
s= r–1, then Eqs. (5) and (6) also characterize the average
Densities of reads crossing all splice-site junctions of either kind in
a gene. It is also useful to compare the change in Density between
intron ends,
DDINT~D30INT{D50INT~DINT(L){DINT(0)~{c0:Sg:TaL ð7Þ
to the difference between the Densities at a pair of splice sites:
D30SS{D50SS~c0:Sg ½T3{TaL ð8Þ
The former extrapolates to zero as L R 0 whereas the latter
equals zero when L=T3/Ta, which is exploited to directly infer
processing times from Densities binned by intron length.
The durations and Densities of exons and splices are only
slightly more complicated. Consider the first exon. Precisely as
described above for introns, the base at position x1 in this exon
(0#x1,L) has a transcription waiting time Ta(L–x1) for the rest of
that exon. Unlike introns, however, the next relevant step is not
intron processing but rather more transcription. In particular,
every base in the first exon further endures for the whole time it
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takes to transcribe the N downstream introns and exons. If we
count all but the 39-most exon, the total transcription waiting time
for this base, up to the end of the last intron, equals
Tt,EXN(x1)~Ta ½(L{x1)z(N{1)LzNL ð9Þ
The countdown to degradation of the mature transcript after a
time Tm begins once the splicing of the final exon pair has been
completed. This depends on the longer of two processes: the total
time T5+T3 to splice out the final intron vs. the time TaL for
transcription of the final exon. The median length of 39-most
exons in mouse and human (which are generally long 39UTRs) are
905 bp and 1036 bp, respectively; their exon transcription times
are typically less than 20 seconds, whereas we find that in all
tissues the mean total splicing time is over 3 minutes. Thus, after
the last intron, it will be usually correct to assume that there is an
additional waiting time T5+T3, followed by the (much longer)
lifetime Tm of the mature mRNA proper until its degradation.
Generalizing to exon number e (1#e#N), the base at position xe
in that exon has total duration
tEXN(xe)~Tt,EXN(xe)zT5zT3zTm ,
Tt,EXN(xe)~Ta (L{xe)z(N{e)Lz(Nz1{e)L½ 
ð10Þ
To be consistent, durations for bases in the very last exon
(e=N+1) have to be treated as a special case. The 59-most base of
this exon is transcribed just after transcription of the last intron has
completed, so this base waits the full time T5+T3 for splicing of
that intron to finish. However, bases lying farther downstream of
the intron, at exonic position xN+1 .0, are created later and thus
have durations that are shorter than that of the 59-most base by an
amount equal to the lag in transcription start time for the base at
xN+1. Hence bases in the final exon have total duration
tEXN(xNz1)~Tt,EXN(xNz1)zT5zT3zTm ,
Tt,EXN(xNz1)~{TaxNz1
ð11Þ
[Of course no duration here is actually negative; this exon’s
bases have lifetimes equal to the total given in Eq. (11).] Since Eq.
(10) with e=N+1 yields the same results as Eq. (11), Eq. (10) can
now be applied to all exons (1#e#N+1). The Density at base xe of
any exon e is therefore
DEXN(xe)~c0:Sg:tEXN(xe)
~c0:Sg Ta (L{xe)z(N{e)Lz(Nz1{e)Lf gzT5zT3zTm
 ð12Þ
The average Density over an entire exon follows from averaging
Eq. (12) over all xe:
DEXN,e~c0:Sg ½Tt,EXN,ezT5zT3zTm ,
Tt,EXN,e~Ta (Nz
1
2
{e)Lz(Nz1{e)L
  ð13Þ
For the average Density over all exons in a gene, we turn to our
definition of Density as total rdbp, the total count of all bases of all
reads of length r that overlap exons, divided by bp, the total
number of bases available in exons (see the MAPtoFeatures
section). For exon number e, with length bpe =L, we have rdbpe
= DEXN,e ? bpe, so the ratio of their totals (sums over e=1,
…,N+1) gives the average exonic Density
DEXN~c0:Sg ½Tt,EXNzT5zT3zTm ,
Tt,EXN~
1
2
Taf (N{1)LzNL g
ð14Þ
Unlike Eqs. (3) and (5) for introns and 59 splice sites, for which
the transcription waiting time involves a single intron, Eq. (14)
shows how newly transcribed exons persist while all downstream
exons and introns (half, on the average) are also transcribed.
Finally, exon-exon splice junctions come into being as soon as
the second step of joining splice sites is complete; these junctions
survive as part of the mature transcript until it is degraded. The
duration of splice number s (1#s#N), from transcription of the
next exon up through the last intron, equals the total transcription
waiting time of N–s exons and N–s introns, less the initial time
T5+T3 for this splice to actually have been finished. Its remaining
time, as for the last exon, equals the waiting time T5+T3 for the last
splice to finish (which cancels out in the total) plus the subsequent
time until mature-RNA degradation. In total, the Density of a
single exon-junction feature is
DEXNJXN,s~c0:Sg ½Tt,EXNJXN,szTm ,
Tt,EXNJXN,s~Ta (N{s)Lz(N{s)Lf g
ð15Þ
For the average Density over all splices in a gene, we assume for
the moment that each splice has the same effective length bps = r–
1; then the ratio of total rdbps = DEXN-JXN,s?bps and total bps
(sums over s=1, …,N) yields
DEXNJXN~c0:Sg ½Tt,EXNJXNzTm ,
Tt,EXNJXN~
1
2
Ta(N{1) LzLf g
ð16Þ
As for the average exon Density, Eqs. (13) – (14), the average
exon-junction Density includes an average waiting time for
transcription of downstream introns and exons.
This simple version of our model for a generic transcript is
summarized by Eqs. (5), (6), (3), (14), and (16), which express
relations between measurable Densities for the five features {59SS,
39SS, INT, EXN, EXN-JXN} and the unknown synthesis rate Sg
and four processing times {T5, T3, Tc, Tm} (and the constants c0
and Ta). Importantly, a sixth relationship, Eq. (4) or (7), also
expresses Sg directly as a change in Density across single introns.
These six expressions are yet further reduced for presentation in
Fig. 1, where we make the additional assumption that exon length
is negligible compared to intron length (L,,L) and call the
single-intron transcription time Tt = TaL. In all applications of
the model, however, all Densities for a gene remain proportional
to the factor c0Sg.
The general version of our model lifts the artificial equal-length
restriction on exons and introns. For individual features, this only
affects the expressions involving transcription waiting times for
exons and exon-exon splice junctions, Eqs. (12) – (13) and (15),
which depend on multiple downstream feature lengths. [Intron
number i and its 59 splice-site junction depend on a single intron
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length L=Li in Eqs. (3) and (5).] Allowing any exon lengths {Le,
e=1, …,N+1}, intron lengths {Li, i=1, …,N}, and effective
splice-feature lengths {ls#r–1, s=1, …,N}, we find
Tt,EXN,e~Ta
1
2
Lez
XN
k~ez1
Lkz
XN
i~e
Li
 
,
e~1, . . . , N{1 ,
Tt,EXN,N~Ta
1
2
LNzLN
 
,
Tt,EXN,Nz1~Ta {
1
2
LNz1
 
ð17Þ
[where again it is understood that the negative time for e=N+1
will be added to T5+T3+Tm, as in Eq. (11)] and
Tt,EXNJXN,s~Ta
XN
k~sz1
Lkz
XN
i~sz1
Li
n o
,
s~1, . . . , N{1 ,
ð18Þ
with Tt,EXN-JXN,N=0. To calculate the average Density over all
features of a certain type in a gene, we again note that the total
contribution of reads to a feature’s bases equals rdbpi = Di?bpi for
feature number i with density Di and length bpi; from these we
find the average Density by dividing the reads’ total contributions
to all feature bases by the total number of bases available for
mapping:
D:
X
i
rdbpiX
i
bpi
~
X
i
Di:bpiX
i
bpi
ð19Þ
Thus, from the individual introns’ Densities in Eq. (3) we obtain
(with bpi = Li)
DINT~
XN
i~1
c0Sg
1
2
TaLizT5zT3zTc
 
:Li
XN
i~1
Li
~c0Sg Tt,INTzT5zT3zTc
 
, Tt,INT~
1
2
Ta
XN
i~1
L2iXN
i~1
Li
ð20Þ
Squared lengths appear here and for other features because
both the average transcription waiting time per base and the
number of bases in the feature are proportional to feature lengths.
Also note that the constants T5, T3, Tc, and Tm common to all
features will appear linearly; details of feature lengths enter only
into Tt,INT and the other mean transcription waiting times.
Overall Densities for the other types of features are calculated in
the same way, namely, as the length-weighted average of their
individual features’ Densities. We collect all the results here in a set
of equations that defines the most general version of our model of
the mRNA life cycle:
SINT~
dDINT
dx
~
DDINT
L
~{c0Sg Ta slope across any intronð Þ
ð21aÞ
D50SS~c0Sg Tt,50SSzT5
 
, Tt,50SS~Ta
XN
i~1
Li
N
ð21bÞ
D30SS~c0Sg T5zT3½  ð21cÞ
DINT~c0Sg Tt,INTzT5zT3zTc
 
,
Tt,INT~Ta
1
2
XN
i~1
L2iXN
i~1
Li
ð21dÞ
DEXN~c0Sg Tt,EXNzT5zT3zTm
 
,
Tt,EXN~Ta
1
2
XN
e~1
Le
 	2
{
1
2
L2Nz1z
XN
e~1
Le
XN
i~e
LiXNz1
e~1
Le
ð21eÞ
DEXNJXN~c0Sg Tt,EXNJXNzTm
 
,
Tt,EXNJXN~Ta
XN{1
s~1
ls
XN
i~sz1
LizLið ÞXN
s~1
ls
ð21fÞ
These six equations generalize those displayed in Fig. 1. This
form of the model applies to genes with one or more introns
(N$1). A singleton exon (N=0) would have DEXN = c0?Sg
[
1
2
TaL+Tm] and zero Density for the other features; for N=1,
there is one splice but Tt,EXN-JXN = 0. The dependence of
transcription waiting times on feature lengths tends to be messy;
though their values might be dominated by long introns, the
longest introns are usually the first two, which also happen to
appear least often in the sums in Eqs. (21e–f), so these expressions
do not generally simplify.
In principle, for each gene g, the solution of Eqs. (21a) – (21f) for
the 5 unknowns {Sg, T5, T3, Tc, Tm} depends straightforwardly
on: the precise measurement of expression levels {D} for 5
different kinds of genomic features, the calculation of transcription
waiting times {Tt} from known feature lengths, and acquisition of
experimental values for the transcription time Ta and sample
concentration constant c0. In practice, there are several compli-
cations.
Firstly, this set is overspecified — there are 6 equations for 5
unknowns. If we were to ignore Eq. (21a), the remaining 5
equations could be divided by Sg to yield 5 equations linear in 5
unknowns: the inititation time 1/Sg and the four processing times,
which we abbreviate {T} = {T5, T3, Tc, Tm}. These equations
are, however, all homogeneous in these 5 variables, in which case
at most 4 of the variables are independent, leaving us once more
with an overspecified set of equations. Equivalently, we could
substitute the value for c0Sg obtained directly from Eq. (21a) into
Eqs. (21b–f), which would yield 5 inhomogeneous equations in the
4 unknowns {T}. One could solve such sets of equations using
linear least-squares methods or some other optimization procedure
to obtain ‘‘best’’ values of {T} for individual genes, including
SnapShot-Seq: In Vivo mRNA Dynamics from RNA-Seq
PLOS ONE | www.plosone.org 13 February 2014 | Volume 9 | Issue 2 | e89673
errors of these estimates, along with the measured synthesis rates
Sg.
Furthermore, two features of the data conspire to defeat this
approach: (1) the Density data for single genes are fairly noisy,
most especially the slopes SlopeINT, and (2) the ‘‘degree of
independence’’ between Eqs. (21e) and (21f), for exons and exon-
exon junctions, is minimal. The latter point hinges on the fact that
mature-transcript degradation times Tm typically turn out to be an
hour or more — always much greater than the transcription times
Tt or processing times {T5, T3, Tc}, which are usually just a few
minutes. The righthand sides of the equations for DEXN and
DEXN-INT therefore tend to be nearly equal, relegating these
expressions to a consistency check rather than independent
information towards a solution. Noisiness in the Density data is
a by-product of the RNA-Seq technique and biological variability,
but to the extent that it is due to counting noise this should be less
of an issue at greater sequencing depth. Also, note that each rate
Sg cannot be determined in absolute units of transcripts initiated
per second — only in the combination c0Sg (Density per time) —
unless sample preparation has allowed for an estimation of c0.
The precise measurement of intron-Density slopes SlopeINT,
Eq. (21a), in order to obtain relative synthesis rates c0Sg, presents
several obstacles. The distribution of our measured Densities
across single introns always has a lot of scatter from sequencing
noise, variations in mappability, and spikes from randomly
inserted repetitive elements. Nevertheless, the longer the intron,
the more likely a straight-line fit would yield a negative slope
significantly different from what would be expected from random
Densities. Such fits produce roughly log-normal distributions of
negative-slope magnitudes |DDINT/L| centered around 10
26 –
1025 (i.e., c0Sg ,0.01 min21) but spread out over 3–4 orders of
magnitude. Despite this wide range of values, when introns of
approximately the same length are aggregated together, their
median slope values are remarkably consistent between length
bins; moreover, aggregated introns generally exhibit the expected
negative slope as a function of distance from either 59 or 39 end.
(Short introns have Density distributions that are so noisy,
however, that positive or negative slopes mostly occur randomly
— another reason for aggregation.) These results suggest that a
practical approach to extracting realistic solutions from the model
Eqs. (21a–f) should involve the aggregation of synthesis rates.
Introns specifically from the same gene, which share the same
synthesis rate, ideally should have negative slopes that reflect this
common rate, taking into account their fitting errors — but even
within genes our data for intron Densities have enough noise to
impose excess variability on slopes.
We employed the following heuristics, first to decide whether
slopes Slopeg,i fit to individual introns were sufficiently informa-
tive, and then to combine intra-genic slopes to estimate a
representative value of c0Sg = –Slopeg,i/Ta for each gene g. As
described in the MAPtoFeatures section, each intron was divided
into 100 equally-spaced bins to which normalized read Densities
were assigned. The slope Slopeg,i of every intron i and the slope’s
standard error eg,i (SE) were calculated from a simple linear least-
squares fit to bins with nonzero Densities {DINT,g,i}. A goodness-
of-fit parameter was taken to be the true-discovery rate (TDR)
under a null model, defined here as equal to one minus the one-
tailed P-value for obtaining this slope value or less with this error
from random data; more significant negative values thus
correspond to TDRg,i R 1. Within each gene, only introns at
least 5 kb in length and with slopes fit to at least 20 bins were
considered usable. Genes that had no such introns were not used
in solving the model for {T}. Candidate genes were assigned a
single slope Slopeg equal to the arithmetic mean of the slopes
{Slopeg,i} of their surviving introns; a propagated error eg for
Slopeg was calculated by combining these introns’ slope errors
{eg,i} in quadrature (the SEs were weighted in proportion to intron
lengths and squared TDRs); and a final TDRg for Slopeg was
calculated from a z-score Slopeg/eg. Further filters applied to
genes used to solve the model were TDRg $0.90 (only the best-
consensus slopes), average DINT,g #1.00 (to remove spikes in
Density), average DEXN,g #50 (to avoid bias from a few very
highly expressed genes), and coding genes only. For our data sets
these steps typically left 1,500–4,000 genes {g} having slopes
deemed adequately reliable for input into Eq. (21a).
The system of 5 equations (21b–f) for the 4 unknowns
processing times {T5, T3, Tc, Tm} nevertheless tends to suffer
instabilities in the following sense. Whether we try to fit the times
using this overspecified set or drop Eq. (21f) and solve for the {T}
exactly, solutions based on feature Densities for a single gene often
include one or more negative times. Such solutions are not
interpretable in our model and should be rejected. In order to
sidestep this issue and still extract a representative range of values
for {T} consistent with the assumptions of our model, we
considered two approaches. We could adjust the various Density
distributions in Eqs. (21a–f) by adding some amount of random
noise, within the limits of our empirically observed noise, that
would optimize the number of genes with ‘‘sensible’’ solutions,
namely, with {T.0} (all times positive). After all, it is noise in our
data that is presumably perturbing this system of equations out of
the region of {T}-parameter space that contains ‘‘stable’’
solutions. Or we could perform Monte Carlo simulations, in
which we would sample the set {g} of filtered genes, aggregate
their observed slopes and feature Densities, and solve the model
for such aggregated samples, repeating as necessary.
In order to calculate lifetimes, we adopted the second approach,
leaving out Eq. (21f) for exon-exon splice junctions and solving the
set of Eqs. (21b–e) for {T} using random samples of N genes as
follows. (Note, however, that to account for errors in the estimated
slopes we do add random gaussian noise to each gene’s mean slope
based on its inferred SE.) For each sample, the genes’ slopes are
geometrically averaged and divided by Ta to yield an aggregated
value of their synthesis rate, c0S = –DD/DT. We similarly
aggregate the sample’s nonzero Densities for each feature type via
their geometric mean (zero Densities are ignored; any sample with
only zero Densities for one or more feature types is discarded).
Each sample’s aggregated Densities are regarded as a vector D =
(D59SS, D39SS, DINT, DEXN), as are the unknown processing times
T = (T5, T3, Tc, Tm) and known transcription waiting times Tt =
(Tt,59SS, Tt,39SS = 0, Tt,INT, Tt,EXN), while the coefficients of T on
the righthand side of Eqs. (21b–e) comprise a 464 matrix M of
zeros and ones. This linear system of 4 equations is solved at once
by inverting M:
T~M{1 D=(c0S){Tt½  ð22Þ
The result is considered valid only if all four processing times are
positive. We gather the valid solutions for many random samples
and characterize their distributions of T5, T3, Tc, and Tm, each of
which tends to be consistent with a log-normal distribution (not
shown). By following this procedure for our pooled data set of 140
million reads from total RNA taken from mouse cortical neurons,
we found 8,517 sets with {T.0} out of 200,000 random samples
of 5 out of 2,338 mouse genes. For each human tissue, we ran
series of 200,000 random samples of size 5 until at least 2,000 valid
solutions were found. Table S4 in File S1 shows the numbers of
SnapShot-Seq: In Vivo mRNA Dynamics from RNA-Seq
PLOS ONE | www.plosone.org 14 February 2014 | Volume 9 | Issue 2 | e89673
total reads, filtered genes used, Monte Carlo samples, and valid
solutions per tissue.
Our chosen sample size of N=5 was an empirical compromise
balancing the advantage of aggregating several genes — to probe
the range of each processing time with greater precision — against
the rarity of useful solutions for too large a sample (e.g., N.20).
Although widths of the calculated processing-time distributions
depend on sample size, they are ultimately limited by the large
variability of the inferred intronic slopes and, to a lesser extent, the
spread of each kind of feature Density.
Statistics, reagents, and animal models
Sample sizes and Replicate numbers. From prior se-
quencing runs, we had determined that the sequencing depth we
used here (,15 M–100 M reads per sample) would allow us to
obtain variations in expressions levels over at least 7 orders of
magnitude, which was more than sufficient for our analyses.
Similarly, previous analyses had suggested that large differences
between samples could be detected using 2–3 biological replicates.
We sequenced only one biological replicate each for our human
tissue samples, so we do not make any claims about significant
differences between tissues. We sequenced three biological
replicates for our isoginkgetin and control treatments. No samples
were excluded from analyses. For animal experiments, no
randomization was used, and no randomization was used to
determine how samples/animals were allocated to experimental
groups. No blinding was used.
Additional details regarding statistical treatment in
Fig. 2. In Fig. 2, processing times for intron splicing, intron
decay, and mRNA decay are obtained from Monte Carlo
simulations, typically several thousands, as described in our
discussions of implementing the SnapShot-Seq model; displayed
error bars indicate either standard error (SE) or, based on the
assumption of normality, or ,1.96 SEs to illustrate 95%
confidence intervals; sample sizes are enumerated in the table
below supplemental Eq. (22).
Distributions of data and statistical test choice. Most of
the data used to generate our figures involve distributions of RNA-
Seq reads from individual samples whose quantification is mostly a
matter of binning and counting. Explicit mention is made when
technical or biological replicates are pooled. Distributions of
expression levels and most other quantities presented here tend to
be log-normal, though upon sufficiently deep sequencing Density
distributions exhibit an additional low-expression mode discussed
in the text. Other distributions displaying principally log-normal
behavior include: expression fold changes and other ratios, such as
mRNA stability (DEXN/D39INT); distances between genes and
between intragenic features; feature lengths; intronic transcription
times (which are proportional to intron length); and RNA
processing and decay times. We therefore use parametric unpaired
t-tests to compare samples between like distributions, unless
otherwise indicated. Note that read counts within individual
features are proportional to Densities as well as feature lengths and
hence do not obey simple Poissonian statistics. Variation within
data groups was similar unless otherwise noted.
Animal models. All animal experiments were approved by
the Harvard Medical School IACUC committee.
Supporting Information
Figure S1 The decrease in expression across introns is not
affected by excised lariat degradation or alternative splicing. (A–D)
Both transcription and intron degradation could in theory
contribute to the slope of intronic expression. (A) Five timelines
of the intron lifecycle, each with different assumptions about the
mechanisms and rates of intron degradation. Models I and IIa
assume a 39-to-59 intronic exonuclease with a rate either equal to
(I) or 10-fold faster (IIa) than that of RNA polymerase II
(RNAPII). Model IIb assumes such a rapid exonuclease rate
(.. 106 that of RNAPII) that it contributes negligibly to the
intronic expression profile. Models IIc and III assume 59-to-39
exonucleases with rates ten times faster than (IIc) or equal to (III)
that of RNAPII. (B) Models I, IIb, and III from A, with 59 and 39
splice sites (SSs) shown, emphasizing that intron degradation does
not affect splice site abundances. (C) For models I, IIb, and III
from A, the resulting intronic and splice site expression profiles.
(D) For all models, predicted changes in the difference in
expression between 59 to 39 ends of introns (or SSs) with increasing
intron length. Only when the rate of exonucleolytic intron
degradation is much faster than the rate of RNAPII are the
slopes for intron ends and splice sites equal. (E) The decrease in
intron density across introns and the decrease in density between
59 and 39 SSs are similar over a wide range of intron lengths,
ruling out a significant contribution of excised lariat degradation to
the intronic expression profile. Error bars represent s.e.m. from
multiple introns from a single representative biological sample. (F)
Approximately 1% of exon-exon splice events are between non-
consecutive exons, while ,3% of annotated exons are detectably
non-consecutively spliced. We required non-consecutive events to
be detected by at least two sequencing reads. Error bars are s.e.m.
from 3 mouse cortical and 5 HeLa biological replicates. All data
are from mouse neurons (using SOLiD), except where noted.
HeLa data were generated using the dUTP/Illumina method.
(PDF)
Figure S2 Increases in intron relative to exon expression in
isoginkgetin-treated cells are not limited to a few genes, and how to
interpret the sawtooth pattern of intronic expression across genes.
(A) Most or all genes have increased intron to exon expression
levels upon isoginkgetin treatment. The x-axis shows a ratio of
ratios, indicating the increase in the intron to exon ratio upon
isoginkgetin (IsoG) treatment. (B) Co-transcriptional versus
obligate post-transcriptional models of splicing can be distin-
guished by how intron read density changes across a gene. In a
model of co-transcriptional splicing in which splicing can occur at
any point after the 39SS has been transcribed (blue), the density at
the 39 end of each intron in a gene is predicted not to vary
systematically along a gene. In obligate post-transcriptional
splicing, in which splicing can only occur once transcription of
the entire gene is complete (orange), intron density declines
continuously from one intron to the next from 59 to 39. Decreases
in intronic expression due to a uniform rate of premature
termination would also be predicted to match the orange model.
Regardless of the rate of splicing, the blue model holds as long as
splicing is able to occur upon completion of intron transcription.
(PDF)
Figure S3 mRNA synthesis rate can be inferred from the density
of reads across introns. The slope of intron density (DDINT/LINT)
is proportional to the mRNA synthesis rate (Fig. 1A) but is difficult
to measure precisely due to counting noise. Intron density (D39INT)
may be measured with greater precision, but it is proportional not
only to the mRNA synthesis rate but also to the time of intron
processing (Tp =T5 + T3 + Tc). Nonetheless, if the variability in
intron processing rates were low enough relative to the variability
in synthesis rates, D39INT would be a useful proxy for synthesis
rate. (A) To evaluate the utility of intron density (D39INT) as a
proxy for synthesis rate, we plotted DDINT/LINT versus D39INT
(total RNA-Seq, mouse neurons) and found a linear least squares
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log-log slope of ,1, indicating nearly direct proportionality
between DDINT/LINT and D39INT. (B) The relationship shown
in panel A holds across ten human tissues. (C) 4SU-Seq exon
densities and total RNA-Seq exon densities are not linearly related
(i.e., do not have a fit slope of 1 on a log-log scale). This result is in
contrast to that for 4SU-Seq exon densities and total RNA-Seq 39
intron densities (Fig. 4D). To make this distinction more obvious,
panel (D) shows an overlay of scatterplots from Fig. 4D and panel
(C). To confirm that RNA-Seq 39 intron densities are a better
indicator of mRNA synthesis rates than RNA-Seq exon densities
across the full range of expression levels, we computed fits for low
expressors vs high expressors (subsets of the data in panel D). Fit
slopes were 0.88 (low expressors) and 0.84 (high expressors) for
4SU densities vs. RNA-Seq 39 intron densities, and fit slopes were
0.90 (low expressors) and 0.72 (high expressors) for 4SU densities
vs. RNA-Seq exon densities. We speculate that expression levels
correlate more tightly with synthesis rates within the low mode of
gene expression due to the ,5-fold lower (median) mRNA
stabilities in this mode (see panels E–F). (E–F) Within each mode,
synthesis rate and mRNA stability contribute equally to expression
levels, as indicated by the fact that the width of each distribution is
similar (FWHM, Full-Width-Half-Max). While both synthesis rates
and mRNA stability are decreased from the high to the low mode,
synthesis rate decreases more. The high mode is shown in E, and
the low mode is shown in F. RNA-Seq data is from lymphocyte
cell lines in C–D and from mouse neurons in E-F.
(PDF)
Figure S4 Bimodality of gene expression is driven by bimodality
of mRNA synthesis. (A) Distributions of gene expression for each
of ten human tissues sequenced using strand-specific total RNA-
Seq on SOLiD. (B) Genes in the low or high modes of gene
expression are also respectively in the low or high modes of mRNA
synthesis, i.e., the low end of the x-distribution is also the low end
of the y-distribution (data from mouse neurons). (C–E) As a
further test of the bimodality of pre-mRNA synthesis rates but not
mRNA stabilities, we confirmed that our 4SU exon (C) and intron
(D) densities were bimodal. In contrast, mRNA stability was
unimodal (E), even when computed using 4SU data. In (E),
mRNA stability was estimated from total RNA-Seq exon densities
(representing expression) divided by 4SU exon densities (repre-
senting synthesis) from the same lymphocyte cell line.
(PDF)
File S1 Contains Tables S1, S3, and S4. Table S1. Average
mRNA lifetimes by Tissue. Table S3. Counts of uniquely aligned
reads for each RNA-Seq library sequenced. Table S4. Summary
of model solutions by tissue.
(XLSX)
Table S2 Gene Ontology analysis, using DAVID, of high
expressors, low expressors, and genes with no detectable
expression.
(XLS)
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